scroll to top
0

Mobile Menu

Header Layout

EBSCO Auth Banner

Let's find your institution. Click here.

Page title

Advanced Search Results For "BIOMARKERS"

1 - 10 of 765,112 results for
 "BIOMARKERS"
Results per page:

Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer.

Publication Type:Academic Journal

Source(s):Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2022 Aug; Vol. 247 (15), pp. 1317-1329. Date of Electronic Publication: 2022 May 06.

Abstract:Inhibin subunit βA ( INHBA ) is a protein-coding gene belonging to the transforming growth factor β (TGFβ) superfamily, which is associated with the development of a variety of cancers. However, the role of INHBA in head and neck squamous cell carcinom...

View details

Hemolymph Glycemia as an Environmental Stress Biomarker in the Invasive Red Swamp Crayfish ( Procambarus clarkii ).

Publication Type:Academic Journal

Source(s):Physiological and biochemical zoology : PBZ [Physiol Biochem Zool] 2022 May-Jun; Vol. 95 (3), pp. 265-277.

Abstract:AbstractSeveral freshwater crayfish species, including Procambarus clarkii , are both ecologically important and commercially important benthic macroinvertebrates, remarkable for their potential to adapt and reproduce but also for their unique abilitie...

View details

Non-Invasive, Topical Sampling of Potential, Low-Molecular Weight, Skin Cancer Biomarkers: A Study on Healthy Volunteers.

Publication Type:Academic Journal

Source(s):Analytical chemistry [Anal Chem] 2022 Apr 19; Vol. 94 (15), pp. 5856-5865. Date of Electronic Publication: 2022 Apr 08.

Abstract:Monitoring of low-molecular weight cancer biomarkers, such as tryptophan (Trp) and its derivative kynurenine (Kyn), might be advantageous to non-invasive skin cancer detection. Thus, we assessed several approaches of topical sampling of Trp and Kyn, in...

View details

Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.

Publication Type:Academic Journal

Source(s):Arthritis research & therapy [Arthritis Res Ther] 2022 Mar 28; Vol. 24 (1), pp. 77. Date of Electronic Publication: 2022 Mar 28.

Abstract:Objective: There is an urgent need to identify novel biomarkers of LN to reflect renal histological changes. This study aims to investigate urinary G3BP levels in LN patients and their association with renal disease activity both clinically and patholo...

View details

Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful?

Publication Type:Editorial & Opinion

Source(s):Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2022 Mar 10; Vol. 60 (6), pp. e136-e137. Date of Electronic Publication: 2022 Mar 10 (Print Publication: 2022).

View details

The role of cystatin C in multiple myeloma.

Publication Type:Academic Journal

Source(s):International journal of laboratory hematology [Int J Lab Hematol] 2022 Feb; Vol. 44 (1), pp. 135-141. Date of Electronic Publication: 2021 Sep 22.

Abstract:Introduction: Renal insufficiency is one of the common complications in multiple myeloma (MM) and an independent factor indicating a poor prognosis. Cystatin C (Cys C) is considered to be expected to replace creatinine to calculate glomerular filtratio...

View details

Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice.

Publication Type:Academic Journal

Source(s):Expert review of proteomics [Expert Rev Proteomics] 2021 Oct; Vol. 18 (10), pp. 881-910. Date of Electronic Publication: 2021 Nov 18.

Abstract:Introduction: Breast cancer (BCa) is the most common cancer type diagnosed in women and 5 th most common cause of deaths among all cancer deaths despite the fact that screening program is at place. This is why novel diagnostics approaches are needed in...

View details

Essential amino acid metabolism-related molecular classification in triple-negative breast cancer.

Publication Type:Academic Journal

Source(s):Epigenomics [Epigenomics] 2021 Aug; Vol. 13 (16), pp. 1247-1268. Date of Electronic Publication: 2021 Aug 27.

Abstract:Aim: To develop an approach to characterize and classify triple-negative breast cancer (TNBC) tumors based upon their essential amino acid (EAA) metabolic activity. Methods: We performed bioinformatic analyses of genomic, transcriptomic and clinical da...

View details

Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.

Publication Type:Academic Journal

Source(s):International journal of laboratory hematology [Int J Lab Hematol] 2021 Jul; Vol. 43 Suppl 1, pp. 86-95.

Abstract:CEBPA-mutant acute myeloid leukemia (AML) encompasses clinically and biologically distinct subtypes of AML in both adults and children. CEBPA-mutant AML may occur with monoallelic (moCEBPA) or biallelic (biCEBPA) mutations, which can be somatic or germ...

View details

Metabolomic biomarkers for hepatocellular carcinoma: A systematic review.

Publication Type:Academic Journal

Source(s):Medicine [Medicine (Baltimore)] 2022 Jan 21; Vol. 101 (3), pp. e28510.

Abstract:Background: Hepatocellular carcinoma (HCC) is a highly malignant cancer which lack of effective diagnosis and prognosis biomarkers, therefore surging studies focused on the metabolite candidates for HCC. The current study was designed to systematically...

View details

banner_970x250 (970x250)

sponsored